Prostate News Archive
18-Aug-2007
Better Prostate Cancer Survival In Most Asian Men Not Explained By Conventional Prognostics (Medical News Today)
Prognostic factors commonly used by clinicians to assess men with prostate cancer do not adequately predict survival outcomes in Asian men living in America, according to the first comprehensive ethnic analysis of Asian-American men with prostate cancer. [click link for full article] EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate ... (PR Newswire via Yahoo! Finance)
EDAP TMS S.A. , the global leader in High Intensity Focused Ultrasound treatment of prostate cancer, is currently conducting clinical investigations in France under an approved clinical trial combining the company's Ablatherm-HIFU device with chemotherapy using docetaxel. New Prostate Cancer Marker Found (WebMD)
Mayo Clinic scientists have found a protein called B7-H3 which may show which prostate cancers are aggressive. ?Use It or Lose It? Theory Applies to Erectile Function after Prostate Surgery (Senior Journal)
Aug. 16, 2007 - The traditional advice given to men after surgery to remove the prostate - to wait for erectile function to return on its own - may not be adequate. Simply put, erections seem to work on a use-it-or-lose-it basis. Prostate cancer immune molecule identified (UPI)
U.S. medical scientists have identified the first immune molecule that appears to play a role in prostate cancer development and progression.
Back to Prostate News Archive
